In the year ended 31 December 2024, Biodexa did not generate any gross revenue
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biotech Alert: Searches spiking for these stocks today
- 3 Penny Stocks to Watch Now, 3/20/25
- Biodexa says on track to initiate Phase 3 trial in FAP next quarter
- Biodexa Pharmaceuticals Advances Phase 3 eRapa Program with FDA Approval
- Biodexa Pharmaceuticals announces outcome of a Type C meeting with FDA on eRapa